Together our data showed that SPRY4 knockdown exhibited similar effects as miR-92a overexpression, which highlighted that the exacerbated effects of miR-92a on NSCLC development were partially mediated by targeting SPRY4. Here, SPRY4 is linked to non-small cell lung carcinoma.